Molecular Partners Ag (MOLN) EBIT Margin (2020 - 2024)
Molecular Partners Ag's EBIT Margin was 358743.33% in Q4 2024, up 360356.51 percentage points from -1613.18% a year earlier and up 360885.62 percentage points from the prior quarter.
Powered by 
Analysis
Molecular Partners Ag (MOLN) EBIT Margin (2020 - 2024) Analysis & Trends
For FY2024, EBIT Margin at Molecular Partners Ag came in at 1224.00%, up 2092.26 percentage points from FY2023.
- EBIT Margin shows a five-year change of +1403.86 percentage points (FY2019 to FY2024).
- In earlier years, EBIT Margin was -868.26% in FY2023 (-929.76 pp), 61.50% in FY2022 (+711.68 pp), -650.17% in FY2021 (-25.97 pp) and -624.21% in FY2020 (-444.35 pp).
- The Q4 2024 figure marks the highest quarterly EBIT Margin in data going back to Q3 2020.
- Compared with a year earlier, EBIT Margin was higher in three of the last eight quarters, with an average year-over-year change of +44516.66 percentage points.
- The best year-over-year quarter for EBIT Margin over five years was Q4 2024 (a gain of 360356.51 percentage points); the worst was Q3 2021 (a drop of 5724.12 percentage points).
- Per Business Quant data, MOLN's EBIT Margin in the three quarters before Q4 2024 was -2142.29% (Q3 2024), -1030.05% (Q2 2024) and -579.18% (Q1 2024).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,130.38 Bn | 1,098.96 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 613.84 Bn | 532.37 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 502.13 Bn | 475.24 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 367.76 Bn | 322.14 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 298.08 Bn | 262.07 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 262.03 Bn | 235.71 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 235.81 Bn | 191.21 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 190.97 Bn | 165.17 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 169.66 Bn | 116.31 Bn | 10.94 Bn | 28.37% |
| 10 | Molecular Partners Ag | 138.65 Mn | -292.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2024 | -2,142.29% |
| Jun 30, 2024 | -1,030.05% |
| Mar 31, 2024 | -579.18% |
| Dec 31, 2023 | -1,613.18% |
| Sep 30, 2023 | -530.85% |
| Jun 30, 2023 | -3,827.23% |
| Mar 31, 2023 | -494.69% |
| Dec 31, 2022 | -554.71% |
| Sep 30, 2022 | -621.49% |
| Jun 30, 2022 | -53.52% |
| Mar 31, 2022 | 88.29% |
| Dec 31, 2021 | -875.17% |
| Sep 30, 2021 | -363.35% |
| Jun 30, 2021 | -472.76% |
| Mar 31, 2021 | -1,896.62% |
| Dec 31, 2020 | -6,251.72% |
| Sep 30, 2020 | 5,360.78% |
API Access
Molecular Partners Ag EBIT Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit-margin&ticker=MOLN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit-margin", "ticker": "MOLN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit-margin&ticker=MOLN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();